Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PAVmed Inc.
  6. News
  7. Summary
    PAVM   US70387R1068

PAVMED INC.

(PAVM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PAVmed : Unveils New Digital Health Subsidiary

06/02/2021 | 11:11am EDT


© MT Newswires 2021
All news about PAVMED INC.
08:30aPAVMED : ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scienti..
BU
10/18LUCID DIAGNOSTICS : Closes $70 Million IPO
MT
10/18PAVMED INC. : Completion of Acquisition or Disposition of Assets (form 8-K)
AQ
10/13PAVMED : Lucid Diagnostics Announces Pricing of Initial Public Offering
BU
10/07PAVMED : to Acquire Medical Device Company CapNostics for Undisclosed Sum
MT
10/07PAVMED : Unit Signs Deal to Buy CapNostics for Undisclosed Sum
MT
10/07PAVMED : Acquires EsophaCap Manufacturer CapNostics LLC (Form 8-K)
PU
10/07PAVMED INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/07PAVMED : Acquires EsophaCap Manufacturer CapNostics LLC
BU
10/07PAVmed Inc. acquired CapNostics, LLC from Martin Von Dyck.
CI
More news
Analyst Recommendations on PAVMED INC.
More recommendations
Financials (USD)
Sales 2021 1,31 M - -
Net income 2021 -42,5 M - -
Net cash 2021 49,0 M - -
P/E ratio 2021 -11,3x
Yield 2021 -
Capitalization 523 M 523 M -
EV / Sales 2021 361x
EV / Sales 2022 54,9x
Nbr of Employees 25
Free-Float 89,1%
Chart PAVMED INC.
Duration : Period :
PAVmed Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PAVMED INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 6,17 $
Average target price 10,00 $
Spread / Average Target 62,1%
EPS Revisions
Managers and Directors
Lishan Aklog Chairman & Chief Executive Officer
Dennis M. McGrath President, Chief Financial Officer & Secretary
Brian J. deGuzman Chief Medical Officer
Michael J. Glennon Vice Chairman
Ronald M. Sparks Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PAVMED INC.191.04%511
THERMO FISHER SCIENTIFIC27.12%238 254
DANAHER CORPORATION38.87%224 750
INTUITIVE SURGICAL, INC.24.61%121 299
SIEMENS HEALTHINEERS AG39.83%76 668
EDWARDS LIFESCIENCES CORPORATION26.06%72 057